HS
VRNA
HighVista Strategies’s Verona Pharma VRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.73M | Buy |
28,880
+12,179
| +73% | +$1.15M | 1% | 23 |
|
2025
Q1 | $1.06M | Sell |
16,701
-7,038
| -30% | -$447K | 0.41% | 106 |
|
2024
Q4 | $1.1M | Hold |
23,739
| – | – | 0.41% | 105 |
|
2024
Q3 | $683K | Sell |
23,739
-8,710
| -27% | -$251K | 0.24% | 108 |
|
2024
Q2 | $469K | Hold |
32,449
| – | – | 0.17% | 117 |
|
2024
Q1 | $522K | Hold |
32,449
| – | – | 0.19% | 116 |
|
2023
Q4 | $645K | Buy |
32,449
+2,576
| +9% | +$51.2K | 0.23% | 109 |
|
2023
Q3 | $487K | Sell |
29,873
-4,154
| -12% | -$67.7K | 0.23% | 111 |
|
2023
Q2 | $719K | Sell |
34,027
-13,696
| -29% | -$290K | 0.33% | 83 |
|
2023
Q1 | $958K | Sell |
47,723
-20,968
| -31% | -$421K | 0.78% | 37 |
|
2022
Q4 | $1.79M | Buy |
+68,691
| New | +$1.79M | 1.07% | 30 |
|
2021
Q2 | – | Sell |
-36,638
| Closed | -$306K | – | 147 |
|
2021
Q1 | $306K | Buy |
36,638
+9,957
| +37% | +$83.2K | 0.23% | 77 |
|
2020
Q4 | $187K | Buy |
+26,681
| New | +$187K | 0.12% | 72 |
|